A greater decrease in left ventricular (LV) volumes from baseline to 6 months was associated with lower clinical event rates between 6 months and 2 years; however, outcomes were not affected by whether patients received transcatheter edge-to-edge repair (TEER) or the severity of mitral regurgitation (MR), according to a new analysis from the COAPT trial.